CALCIUM ANTAGONISTS: PHARMACOKINETIC PROPERTIESKATES RE.1983; DRUGS (NEW YORK); ISSN 0012-6667; USA; DA. 1983; VOL. 25; NO 2; PP. 113-124; BIBL. 37 REF.Article

UNIFORMITY TEST FOR THE METHOD OF STRAINED COORDINATESKATES RE.1981; SIAM J. APPL. MATH.; ISSN 0036-1399; USA; DA. 1981; VOL. 41; NO 2; PP. 265-270; BIBL. 17 REF.Article

GRAVITATIONAL RADIATION DAMPING OF BINARY SYSTEM CONTAINING COMPACT OBJECTS CALCULATED USING MATCHED ASYMPTOTIC EXPENSIONSKATES RE.1980; PHYS. REV. D; ISSN 0556-2821; USA; DA. 1980; VOL. 22; NO 8; PP. 1871-1879; BIBL. 23 REF.Article

MOTION OF AN ELECTRICALLY OR MAGNETICALLY CHARGED BODY WITH POSSIBLY STRONG INTERNAL GRAVITY THROUGH EXTERNAL ELECTROMAGNETIC AND GRAVITATIONAL FIELDSKATES RE.1980; PHYS. REV. D; ISSN 0556-2821; USA; DA. 1980; VOL. 22; NO 8; PP. 1879-1881; BIBL. 10 REF.Article

POINT-SOURCE IDEALIZATION IN CLASSICAL FIELD THEORIES. I: ELECTROMAGNETIC RADIATION DAMPING OF A SYSTEM OF TWO PERTURBED REISSNER-NORDSTROEM SINGULARITIES IN THE SLOW-MOTION LIMITKATES RE.1982; PHYS. REV. D; ISSN 0556-2821; USA; DA. 1982; VOL. 25; NO 10; PP. 2487-2493; BIBL. 20 REF.Article

THERAPEUTIC MONITORING OF ANTIARRHYTHMIC DRUGSKATES RE.1980; THER. DRUG MONIT.; USA; DA. 1980; VOL. 2; NO 2; PP. 119-126; BIBL. 55 REF.Article

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC ANALYSIS OF LORCAINIDE AND ITS ACTIVE METABOLITE, NORLORCAINIDE, IN HUMAN PLASMAYEE YG; KATES RE.1981; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1981; VOL. 223; NO 2; PP. 454-459; BIBL. 5 REF.Article

POINT-SOURCE IDEALIZATION IN CLASSICAL FIELD THEORIES. II: MECHANICAL ENERGY LOSSES FROM ELECTROMAGNETIC RADIATION REACTIONKATES RE; ROSENBLUM A.1982; PHYS. REV. D; ISSN 0556-2821; USA; DA. 1982; VOL. 25; NO 10; PP. 2494-2498; BIBL. 12 REF.Article

CLINICAL PHARMACOKINETICS OF N-ACETYLPROCAINAMIDECONNOLLY SJ; KATES RE.1982; CLIN. PHARMACOKINET.; ISSN 0312-5963; AUS; DA. 1982; VOL. 7; NO 3; PP. 206-220; BIBL. 2 P.Article

BILIARY SECRETION OF METHOTREXATE IN RATS AND ITS INHIBITION BY PROBENECID.KATES RE; TOZER TN.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 9; PP. 1348-1352; BIBL. 21 REF.Article

MYOCARDIAL DISPOSITION AN CARDIAC PHARMACODYNAMICS OF VERAPAMIL IN THE DOGKEEFE DL; KATES RE.1982; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1982; VOL. 220; NO 1; PP. 91-96; BIBL. 20 REF.Article

PHENYTOIN-INDUCED CHANGES IN QUINIDINE AND 3-HYDROXY-QUINIDINE PHARMACOKINETICS IN CONSCIOUS DOGSJAILLON P; KATES RE.1980; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1980; VOL. 213; NO 1; PP. 33-37; BIBL. 16 REF.Article

DISPOSITION KINETICS OF ORAL QUINIDINE WHEN ADMINISTERED CONCURRENTLY WITH PROPRANOLOLKATES RE; BLANFORD MF.1979; J. CLIN. PHARMACOL.; USA; DA. 1979; VOL. 19; NO 7; PP. 378-383; BIBL. 25 REF.Article

RAPID HIGH-PRESSURE LIQUID CHROMATOGRAPHIC ANALYSIS OF VERAPAMIL IN BLOOD AND PLASMAHARAPAT SR; KATES RE.1979; J. CHROMATOGR.; NLD; DA. 1979; VOL. 170; NO 2; PP. 385-390; BIBL. 7 REF.Article

DOBUTAMINE PHARMACOKINETICS IN SEVERE HEART FAILUREKATES RE; LEIER CV.1978; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1978; VOL. 24; NO 5; PP. 537-541; BIBL. 7 REF.Article

RAPID GLC DETERMINATION OF PROPRANOLOL IN HUMAN PLASMA SAMPLES.KATES RE; JONES CL.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 10; PP. 1490-1492; BIBL. 7 REF.Article

USE OF HYPERFUNCTIONS FOR CLASSICAL RADIATION-REACTION CALCULATIONSROSENBLUM A; KATES RE; HAVAS P et al.1982; PHYS. REV. D; ISSN 0556-2821; USA; DA. 1982; VOL. 26; NO 10; PP. 2707-2712; BIBL. 24 REF.Article

THE RELATIONSHIP BETWEEN PLASMA DOBUTAMINE CONCENTRATIONS AND CARDIOVASCULAR RESPONSES IN CARDIAC FAILURELEIER CV; UNVERFERTH DV; KATES RE et al.1979; AMER. J. MED.; USA; DA. 1979; VOL. 66; NO 2; PP. 238-242; BIBL. 12 REF.Article

BINDING OF QUINIDINE TO PLASMA PROTEINS IN NORMAL SUBJECTS AND IN PATIENTS WITH HYPERLIPROTEINEMIAS.KATES RE; SOKOLOSKI TD; COMSTOCK TJ et al.1978; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1978; VOL. 23; NO 1; PP. 30-35; BIBL. 14 REF.Article

METABOLITE CUMULATION DURING LONG-TERM ORAL ENCAINIDE ADMINISTRATIONKATES RE; HARRISON DC; WINKLE RA et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 4; PP. 427-432; BIBL. 9 REF.Article

VERAPAMIL PROTEIN BINDING IN PATIENTS AND IN NORMAL SUBJECTSKEEFE DL; YIN GAIL YEE; KATES RE et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 29; NO 1; PP. 21-26; BIBL. 15 REF.Article

INCREASED METHOTREXATE TOXICITY DUE TO CONCURRENT PROBENECID ADMINISTRATIONKATES RE; TOZER TN; SORBY DL et al.1976; BIOCHEM. PHARMACOL.; G.B.; DA. 1976; VOL. 25; NO 13; PP. 1485-1488; BIBL. 19 REF.Article

NEW ANTIARRHYTHMIC DRUGS: THEIR PLACE IN THERAPYKEEFE DLD; KATES RE; HARRISON DC et al.1981; DRUGS (N. Y.); ISSN 0012-6667; USA; DA. 1981; VOL. 22; NO 5; PP. 363-400; BIBL. 8 P.Article

TOLERANCE TO DOBUTAMINE AFTER A 72 HOUR CONTINUOUS INFUSIONUNVERFERTH DV; BLANFORD M; KATES RE et al.1980; AMER. J. MED.; USA; DA. 1980; VOL. 69; NO 2; PP. 262-266; BIBL. 22 REF.Article

CLINICAL PHARMACOLOGY AND ANTIARRHYTHMIC EFFICACY OF ENCAINIDE IN PATIENTS WITH CHRONIC VENTRICULAR ARRHYTHMIASWINKLE RA; PETERS F; KATES RE et al.1981; CIRCULATION; ISSN 0009-7322; USA; DA. 1981; VOL. 64; NO 2; PP. 290-296; BIBL. 15 REF.Article